Back to search

Article

Nicotinamide riboside alleviates Parkinson’s disease symptoms but downregulates dopamine metabolism upon lactacystin-induced proteostasis failure

2021-03-12

Abstract excerpt

Activation of mitochondrial metabolism and proteostasis with the NAD + precursor nicotinamide riboside (NR) has emerged as a potential therapeutic approach for neurodegenerative disorders including Parkinson’s disease (PD). However, despite recently started clinical trials, studies on NR in animal models of PD are scarce. In this study, we investigated the effect of NR in multiple models of PD. In transgenic C....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e54c3347-a7e3-58c0-85fb-6b3927acf9a5
DOI
10.1101/2021.03.12.435062
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nicotinamide riboside alleviates Parkinson’s disease symptoms but downregulates dopamine metabolism upon lactacystin-induced proteostasis failureDOI 10.1101/2021.03.12.435062
Select a neighboring publication to make it the new centre.